Arteaga CL. Overview of epidevmal growth factor receptor biology and its voles as a therapeutic taraget in human neoplasia [J].Semin Oncol,2002(14):2915.
[2]
Nicholson RI,Gee JMW,Harper ME.EGFR and cancer prognosis[J]. Eur J Cancer,2001,37l(4):9-15.
[3]
Kopp R, Rothbauer E, Ruge M,et al.Clinical implications of the EGF veceptor/ligand system for tumor progression and survival in gastrointestinal carcinomous:Evidence for new therapeutic options [J].Recent Results Cancer Res,2003,162(1):115-132.
[4]
Pinto-de-Sousa J, David L, Almeida R,et al. C-erbB-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric cavcinoma[J].Int J Surg Pathol,2002,10(4):247-256.
[5]
Garcia I,Vizoso F,Mavtin A,et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer [J].Ann Surg Oncal,2003,10(3):234-241.
[6]
Gong SJ,Lin CJ, Rha SY, et al.Growth inhibitory effects of trastuzumat and chemotherapeutic drugs in gastric cancer cell lines[J].Cancer Lett,2004,214(2):215-224.
